These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3427593)

  • 1. [Therapeutic effect of silymarin in patients with liver cirrhosis].
    Kupcová V; Turecký L; Holomán J; Ulicná O; Brixová E; Volmut J
    Cas Lek Cesk; 1987 Nov; 126(45):1406-9. PubMed ID: 3427593
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
    Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F
    Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of silymarin on the anti-fibrosis of liver and its mechanism].
    Wang Y; Jia JD
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1219-21. PubMed ID: 16029603
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver cell protection in toxic liver lesion.
    Fehér J; Cornides A; Pál J; Láng I; Csomós G
    Acta Physiol Hung; 1989; 73(2-3):285-91. PubMed ID: 2596318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Silymarin in liver cirrhosis].
    Benda L; Zenz W
    Wien Med Wochenschr; 1973 Sep; 123(3):512-6. PubMed ID: 4748151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M; Fontana M; Sebastiani F; Parenzi A
    Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the therapeutic effects of silymarin].
    Margaroli P; Rossi M; Arcabasso GD; Cosini I; Malacrida C
    Clin Ter; 1980 Dec; 95(6):663-72. PubMed ID: 7214856
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of carsil and legalon in treating chronic liver diseases].
    Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G
    Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
    Ferenci P; Dragosics B; Dittrich H; Frank H; Benda L; Lochs H; Meryn S; Base W; Schneider B
    J Hepatol; 1989 Jul; 9(1):105-13. PubMed ID: 2671116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Silymarin and various problems of current therapy of chronic liver diseases].
    Fassati P; Fassati M
    Cas Lek Cesk; 1973; 112(28):865-9. PubMed ID: 4720441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Silymarin treatment of alcoholic liver disease].
    Orv Hetil; 1990 Jul; 131(29):1607-9. PubMed ID: 2392321
    [No Abstract]   [Full Text] [Related]  

  • 17. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 18. Free radicals in tissue damage in liver diseases and therapeutic approach.
    Fehér J; Láng I; Deák G; Cornides A; Nékám K; Gergely P
    Tokai J Exp Clin Med; 1986; 11 Suppl():121-34. PubMed ID: 3452238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of silymarin in the treatment of alcoholic hepatic steatosis].
    Canini F; Bartolucci L; Cristallini E; Gradoli C; Rossi A; Ribacchi R; Valori C
    Clin Ter; 1985 Aug; 114(4):307-14. PubMed ID: 4053546
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
    Siegers CP
    Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.